List of Excipients in API butalbital, aspirin, caffeine and codeine phosphate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing butalbital, aspirin, caffeine and codeine phosphate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Actavis Pharma Inc | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | butalbital, aspirin, caffeine and codeine phosphate | 0591-3546 | CELLULOSE, MICROCRYSTALLINE | |
| Actavis Pharma Inc | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | butalbital, aspirin, caffeine and codeine phosphate | 0591-3546 | D&C YELLOW NO. 10 | |
| Actavis Pharma Inc | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | butalbital, aspirin, caffeine and codeine phosphate | 0591-3546 | FD&C BLUE NO. 1 | |
| Actavis Pharma Inc | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | butalbital, aspirin, caffeine and codeine phosphate | 0591-3546 | FD&C RED NO. 3 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing butalbital, aspirin, caffeine and codeine phosphate
Detailed excipient profiles for butalbital, aspirin, caffeine and codeine phosphate
Excipient focus: ALUMINUM OXIDE
butalbital, aspirin, caffeine and codeine phosphate drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | butalbital, aspirin, caffeine and codeine phosphate | 0527-1312 |
| Amneal Pharmaceuticals of New York LLC | butalbital, aspirin, caffeine and codeine phosphate | 69238-1993 |
| >Company | >Ingredient | >NDC |
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing ALUMINUM OXIDE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
butalbital, aspirin, caffeine and codeine phosphate drug variants containing CELLULOSE, MICROCRYSTALLINE
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 28
butalbital, aspirin, caffeine and codeine phosphate drug variants containing D&C RED NO. 28
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | butalbital, aspirin, caffeine and codeine phosphate | 0591-3546 |
| Physicians Total Care Inc | butalbital, aspirin, caffeine and codeine phosphate | 54868-1037 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 33
butalbital, aspirin, caffeine and codeine phosphate drug variants containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | butalbital, aspirin, caffeine and codeine phosphate | 0527-1312 |
| Amneal Pharmaceuticals of New York LLC | butalbital, aspirin, caffeine and codeine phosphate | 69238-1993 |
| >Company | >Ingredient | >NDC |
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing D&C RED NO. 33
Excipient focus: D&C YELLOW NO. 10
butalbital, aspirin, caffeine and codeine phosphate drug variants containing D&C YELLOW NO. 10
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
butalbital, aspirin, caffeine and codeine phosphate drug variants containing FD&C BLUE NO. 1
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
butalbital, aspirin, caffeine and codeine phosphate drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | butalbital, aspirin, caffeine and codeine phosphate | 0527-1312 |
| Amneal Pharmaceuticals of New York LLC | butalbital, aspirin, caffeine and codeine phosphate | 69238-1993 |
| >Company | >Ingredient | >NDC |
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 3
butalbital, aspirin, caffeine and codeine phosphate drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | butalbital, aspirin, caffeine and codeine phosphate | 0591-3546 |
| Physicians Total Care Inc | butalbital, aspirin, caffeine and codeine phosphate | 54868-1037 |
| >Company | >Ingredient | >NDC |
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
butalbital, aspirin, caffeine and codeine phosphate drug variants containing FD&C RED NO. 40
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | butalbital, aspirin, caffeine and codeine phosphate | 0591-3546 |
| Physicians Total Care Inc | butalbital, aspirin, caffeine and codeine phosphate | 54868-1037 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
butalbital, aspirin, caffeine and codeine phosphate drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | butalbital, aspirin, caffeine and codeine phosphate | 0591-3546 |
| Physicians Total Care Inc | butalbital, aspirin, caffeine and codeine phosphate | 54868-1037 |
| >Company | >Ingredient | >NDC |
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
butalbital, aspirin, caffeine and codeine phosphate drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | butalbital, aspirin, caffeine and codeine phosphate | 0591-3546 |
| Physicians Total Care Inc | butalbital, aspirin, caffeine and codeine phosphate | 54868-1037 |
| >Company | >Ingredient | >NDC |
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing FERRIC OXIDE RED
Excipient focus: GELATIN
butalbital, aspirin, caffeine and codeine phosphate drug variants containing GELATIN
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
butalbital, aspirin, caffeine and codeine phosphate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | butalbital, aspirin, caffeine and codeine phosphate | 0527-1312 |
| Amneal Pharmaceuticals of New York LLC | butalbital, aspirin, caffeine and codeine phosphate | 69238-1993 |
| >Company | >Ingredient | >NDC |
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
butalbital, aspirin, caffeine and codeine phosphate drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | butalbital, aspirin, caffeine and codeine phosphate | 51991-074 |
| Bryant Ranch Prepack | butalbital, aspirin, caffeine and codeine phosphate | 63629-2952 |
| >Company | >Ingredient | >NDC |
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: STARCH, CORN
butalbital, aspirin, caffeine and codeine phosphate drug variants containing STARCH, CORN
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
butalbital, aspirin, caffeine and codeine phosphate drug variants containing STEARIC ACID
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | butalbital, aspirin, caffeine and codeine phosphate | 0591-3546 |
| Physicians Total Care Inc | butalbital, aspirin, caffeine and codeine phosphate | 54868-1037 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
butalbital, aspirin, caffeine and codeine phosphate drug variants containing TALC
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
butalbital, aspirin, caffeine and codeine phosphate drug variants containing TITANIUM DIOXIDE
butalbital, aspirin, caffeine and codeine phosphate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
